Letter to the Editor Regarding “Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023”
本文未提供摘要，请点击“查看全文”查看完整内容。